<DOC>
	<DOCNO>NCT01279200</DOCNO>
	<brief_summary>The purpose study investigate monitoring method ovulation induction cycle letrozole effect pregnancy rate . Monitoring ovulation induction cycle letrozole do variety method , two commonly utilized home-based urinary LH kit ( ovulation predictor kit ) office-based midcycle follicular ultrasound . Letrozole couple follicular monitoring ultrasound may add extra cost per cycle improvement fecundability ( pregnancy rate per cycle ) .</brief_summary>
	<brief_title>Use High Cost Monitoring During Letrozole Ovulation Induction</brief_title>
	<detailed_description>The study randomize control trial adult woman primary secondary infertility see University Michigan Health System undergo ovulation induction ( OI ) letrozole part standard clinical care . Patients undergo OI letrozole per standard clinical care randomize urinary luteinizing hormone ( LH ) ovulation predictor kit use versus mid-cycle ultrasound administration hCG appropriate timing intercourse intrauterine insemination . Patients prescribed letrozole per routine clinical care approach determine willingness participate study . Study period involve three ovulation induction cycle pregnancy occur .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>Women age 2139 undergoing letrozole ovulation induction ( part routine clinical care ) single academicinfertility center . Normal uterus evidence least tubal patency one side ( assessed salineinfusion sonography hysterosalpingogram per clinical care ) . Current pregnancy Nursing mother Prior hypersensitivity hCG preparation Primary ovarian failure menopausal level FSH ( &gt; 12 mIU/mL ) Patients abnormal uterine bleeding undetermined origin ovarian cyst undetermined origin , sexhormone dependent tumor , document bilateral tubal obstruction , uncorrected uterine anomaly , Previous letrozole gonadotropin use and/or previous treatment vitro fertilization Other uncorrected medical condition would contraindication attempt elective ovulation induction ( e.g. , uncontrolled diabetes , intracranial lesion , thyroid adrenal disease ) .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>letrozole</keyword>
	<keyword>ovulation monitoring</keyword>
	<keyword>pregnancy rate</keyword>
</DOC>